Featured Research

from universities, journals, and other organizations

Experimental Drug Decreases Age-Related Blood Vessel Stiffening

Date:
March 23, 2001
Source:
Johns Hopkins Medical Institutions
Summary:
An experimental drug may reverse the stiffening of the cardiovascular system that occurs with aging, according to results of a clinical trial conducted at nine sites throughout the United States and led by Johns Hopkins physicians.

An experimental drug may reverse the stiffening of the cardiovascular system that occurs with aging, according to results of a clinical trial conducted at nine sites throughout the United States and led by Johns Hopkins physicians.

Vascular stiffening and its increase in the pulsing of blood pressure and systolic hypertension is a "huge epidemiological problem," affecting about half of all individuals over the age of 60, says David A. Kass, M.D., professor of medicine and biomedical engineering at Hopkins and principal investigator of the trial.

In a group of older people who had evidence of vascular stiffening, the drug, ALT-711, significantly reduced arterial pulse pressure, defined as the difference between systolic blood pressure (the upper number) and diastolic blood pressure (the lower number). It also improved the ability of blood vessels to stretch by up to18 percent. Many recent epidemiological studies have shown that pulse pressure is the leading risk factor for cardiovascular disease in the elderly.

During the trial, researchers studied 93 adults older than age 50 with measurably stiffened blood vessels and a systolic blood pressure of at least 140 mmHg. Patients took a drug tablet or a placebo once a day for eight weeks. Researchers recorded their blood pressure, the flexibility or compliance of their arteries and blood flow through the heart, among other factors.

The medication works by breaking up so-called advanced glycosylated (sugar-based) crosslink endproducts (known as AGE) that form between proteins, and occur with aging and/or the altered body chemistry associated with diabetes. These crosslinks particularly target proteins that are long lived -- such as the structural proteins in the artery wall that are responsible for its ability to stretch. The more crosslinks, the stiffer the related tissues. This affects the cornea, bladder, arteries and possibly the heart. In the cardiovascular system, AGE results in a loss of elasticity. This in turn causes an increase in blood pressure pulsing, a change that is linked to vascular disease and atherosclerosis, and also increases the heart's workload. The latter is linked to an increased risk of heart attack, heart failure and coronary artery disease.

"Prior drugs to treat this common type of blood pressure problem mostly have focused on lowering the mean or average pressure by relaxing the peripheral arteries that regulate resistance," says Kass. "ALT-711 appears to be different. It acts on the larger vessels that regulate stiffness. This may represent a novel therapeutic approach for patients with arterial stiffening associated with aging, diabetes and systolic hypertension."

###

Related Web sites:

American College of Cardiology 50th Scientific Sessions -- http://www.acc.org/2001ann_meeting/home.htm

Information on Heart Disease Treatments at Johns Hopkins -- http://www.hopkinsmedicine.org/heartdisease.html


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Experimental Drug Decreases Age-Related Blood Vessel Stiffening." ScienceDaily. ScienceDaily, 23 March 2001. <www.sciencedaily.com/releases/2001/03/010321073249.htm>.
Johns Hopkins Medical Institutions. (2001, March 23). Experimental Drug Decreases Age-Related Blood Vessel Stiffening. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2001/03/010321073249.htm
Johns Hopkins Medical Institutions. "Experimental Drug Decreases Age-Related Blood Vessel Stiffening." ScienceDaily. www.sciencedaily.com/releases/2001/03/010321073249.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins